The Multiple Coagulation Tests System (MCTS) is a cutting edge coagulation analyzer that determines whether a coagulation disorder is truly present and, if so, determines the best therapy to treat the coagulation disorder. The MCTS offers several major benefits to patients and hospitals.

1) It determines the best therapy and dose of the therapy to stop bleeding in a patient, thereby eliminating unnecessary blood transfusions.

2) Risk of a patient acquiring a blood borne transmissible disease is decreased, as is the risk of a transfusion reaction.

3) Hospital blood bank costs are reduced, as is their legal liability.